Cargando…

Update on treatment of follicular non-Hodgkin’s lymphoma: focus on potential of bortezomib

Follicular lymphoma is predominantly managed as a chronic disease, with intermittent chemo/immunotherapy reserved for symptomatic progression. It is considered incurable with conventional treatments, and current therapeutic options are associated with significant toxicities that are especially limit...

Descripción completa

Detalles Bibliográficos
Autores principales: Brander, Danielle M, Beaven, Anne W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3333814/
https://www.ncbi.nlm.nih.gov/pubmed/22536060
http://dx.doi.org/10.2147/PPA.S23241